Please login to the form below

Not currently logged in
Email:
Password:

sevelamer

This page shows the latest sevelamer news and features for those working in and with pharma, biotech and healthcare.

Generic competition for Sanofi's Renvela hits UK market

Generic competition for Sanofi's Renvela hits UK market

Teva UK and a number of other generic companies have launched their versions of Sanofi's Renvela (sevelamer carbonate), following the expiry of the drug's patent in the country. ... Renvela is a next-generation version of Renagel (sevelamer hydrochloride)

Latest news

  • Orphan drugs in latest CHMP recommendations Orphan drugs in latest CHMP recommendations

    Completing the positive opinions were two new informed consent applications: Sevelamer carbonate Zentiva (sevelamer) from Genzyme for the control of hyperphosphataemia in adults receiving haemodialysis or peritoneal dialysis and Rasagiline

  • Trials and tribulations

    Sevelamer carbonate. Renvela (Genzyme Corporation). Hypophosphataemia. US. Hydrocodone/ibuprofen. Ibudone (ProEthic Pharmaceuticals).

  • News in brief, May 02, 2007

    The tablet facility supplies the global market with Renagel (sevelamer), a phosphate binder used in the treatment of chronic kidney disease for patients on dialysis.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics